Lifelong Monitoring and Surveillance
At a Glance
Woodhouse-Sakati syndrome requires individualized lifelong follow-up rather than one fixed schedule. Monitoring commonly includes yearly diabetes, thyroid, and hearing checks, with movement evaluations and heart, brain MRI, puberty, and bone health testing based on symptoms, age, and treatment.
Because Woodhouse-Sakati syndrome (WSS) is a progressive condition for some, living with it is not just about the initial diagnosis—it is about staying ahead of changes through consistent monitoring. While WSS is a lifelong challenge, many of the symptoms can be managed effectively when caught early through regular surveillance [1][2].
Because every person with WSS follows a different path, there is no single “one-size-fits-all” schedule. Instead, your doctors will build a plan tailored to your or your child’s specific needs, using the following areas as a guide.
Hormone and Metabolic Health
Hormone issues can emerge at different stages of life. Even if your blood work is normal today, regular check-ups are essential to catch new developments like diabetes or thyroid changes [3][4].
- Diabetes Screening: Doctors generally recommend annual testing for HbA1c and fasting glucose, especially as children enter their teenage years [4][5]. If you notice signs like excessive thirst or frequent urination, these tests should be done sooner. Remember that a sick-day plan is crucial if you begin treatment for diabetes.
- Thyroid Function: Annual testing for TSH and Free T4 helps ensure the body’s metabolism is functioning correctly [6][3].
- Puberty and Bone Health: Periodic checks of sex hormones (like estrogen or testosterone) and bone density scans are often used to monitor the effectiveness of hormone replacement therapy, depending on the person’s age and treatment [7][5].
Neurological and Imaging Follow-Up
WSS can cause changes in the brain’s “white matter” (the wiring) and lead to iron deposits in the areas that control movement [8][9].
- Brain MRI: While there is no rule for how often to repeat an MRI, doctors may order a new scan if there are new symptoms, such as worsening tremors or muscle stiffness [8][4]. While some follow-up imaging has shown expansion of white-matter lesions in small cohorts, imaging changes do not automatically predict clinical decline [8]. Repeat imaging should be directed by your specialist based on symptoms.
- Movement Evaluations: Regular visits with a neurologist help track dystonia (muscle spasms) and other movement issues. Using standard scales like the BFMDRS, your team can measure whether treatments—like medication or therapy—are working [10][11].
Hearing and Heart Health
Some symptoms of WSS are “silent” and can only be detected through specialized testing.
- Comprehensive Audiology: Because hearing loss in WSS is often progressive and can start in childhood, an annual hearing test (audiogram) is highly recommended [6][12]. It is important to know that simple “evoked potential” tests (BAEPs) can sometimes miss hearing loss in WSS, so a comprehensive exam is best [13].
- Cardiac Baseline: Some reports have noted unusual heart rhythms (ECG abnormalities) or fainting (syncope) in people with WSS [14][15]. Your team may recommend a baseline ECG (electrocardiogram) to check your heart’s electrical activity [14].
An Individualized Discussion Guide
Rather than a rigid calendar, use the list below as a framework to discuss monitoring with your specialists. Ask your doctor: Which of these tests do I need, when do I need them, and who will order them?
- Metabolic: HbA1c, Fasting Glucose. (Tests like C-peptide are not generally used for routine screening in asymptomatic people, but may be used to classify diabetes once it appears).
- Endocrine: TSH, Free T4, Sex Hormones.
- Auditory: Comprehensive Audiogram.
- Neurologic: Movement & Swallowing Screen.
- Imaging: Brain MRI (As needed for new symptoms).
- Cardiac: ECG (Electrocardiogram) (Baseline; then as needed).
Quality of Life and Vigilance
Living with an ultra-rare disease requires a balance of vigilance and living your life. It is normal to feel “on guard” for new symptoms, but having a clear monitoring plan in place can actually reduce anxiety by ensuring that if changes happen, they are caught and treated quickly [2]. Your multidisciplinary team is there to help you manage this journey, allowing you to focus on well-being and daily activities [1][16].
Common questions in this guide
What routine blood tests are used to monitor Woodhouse-Sakati syndrome?
How often should a person with WSS have a brain MRI?
What kind of hearing test is best for WSS?
Is an ECG part of Woodhouse-Sakati syndrome monitoring?
How are movement and swallowing changes followed in WSS?
How are puberty and bone health monitored in Woodhouse-Sakati syndrome?
Get notified when new evidence is published on Woodhouse-Sakati syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Three Siblings With Woodhouse-Sakati Syndrome: A Case Report of A New Saudi Family.
Alhuzaim ON, Ahmad MM, Sherbeeni SM, et al.
Cureus 2022; (14(12)):e32225 doi:10.7759/cureus.32225.
PMID: 36620807 - 2
Woodhouse-sakati syndrome with no reportable MRI findings: a case report.
Irvine RE, Ahmad A
BMC neurology 2024; (24(1)):359 doi:10.1186/s12883-024-03865-z.
PMID: 39342163 - 3
A case of Woodhouse-Sakati syndrome with pituitary iron deposition, cardiac and intestinal anomalies, with a novel mutation in DCAF17.
Sendur SN, Oguz S, Utine GE, et al.
European journal of medical genetics 2019; (62(8)):103687 doi:10.1016/j.ejmg.2019.103687.
PMID: 31152917 - 4
Woodhouse-Sakati Syndrome: First report of a Portuguese case.
Louro P, Durães J, Oliveira D, et al.
American journal of medical genetics. Part A 2019; (179(11)):2237-2240 doi:10.1002/ajmg.a.61303.
PMID: 31347785 - 5
Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care centre with characterization of the primary gonadal failure.
Das L, Rai A, Mavuduru R, et al.
Endocrine 2020; (69(2)):420-429 doi:10.1007/s12020-020-02320-6.
PMID: 32350710 - 6
Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.
Ali R, Al-Dewik N, Mohammed S, et al.
American journal of medical genetics. Part A 2022; (188(1)):116-129 doi:10.1002/ajmg.a.62501.
PMID: 34590781 - 7
The Successful Management of Primary Amenorrhea in Woodhouse-Sakati Syndrome: A Case Report and a Literature Review.
Bakhsh H, Alqntash N, Almajed E
Life (Basel, Switzerland) 2023; (13(10)) doi:10.3390/life13102022.
PMID: 37895404 - 8
Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.
Abusrair AH, Bohlega S, Al-Semari A, et al.
AJNR. American journal of neuroradiology 2018; (39(12)):2256-2262 doi:10.3174/ajnr.A5879.
PMID: 30409855 - 9
Neurodegeneration with Brain Iron Accumulation.
Schipper DA, Schipper HM
Advances in experimental medicine and biology 2025; (1480()):291-309 doi:10.1007/978-3-031-92033-2_19.
PMID: 40603798 - 10
Long-Term Outcomes of Deep Brain Stimulation in Woodhouse-Sakati Syndrome.
Alhodaif H, Alkhodair Y, Alotaibi F, et al.
Movement disorders : official journal of the Movement Disorder Society 2026; (41(6)):1427-1433 doi:10.1002/mds.70266.
PMID: 41902420 - 11
Deep Brain Stimulation in Rare Inherited Dystonias.
Beaulieu-Boire I, Aquino CC, Fasano A, et al.
Brain stimulation 2016; (9(6)):905-910 doi:10.1016/j.brs.2016.07.009.
PMID: 27743838 - 12
Neurosensory Affectation in Patients Affected by Wolfram Syndrome: Descriptive and Longitudinal Analysis.
Esteban-Bueno G, Berenguel Hernández AM, Fernández Fernández N, et al.
Healthcare (Basel, Switzerland) 2023; (11(13)) doi:10.3390/healthcare11131888.
PMID: 37444722 - 13
Multimodal Evoked Potential Profiles in Woodhouse-Sakati Syndrome.
Abusrair A, AlHamoud I, Bohlega S
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2022; (39(6)):504-509 doi:10.1097/WNP.0000000000000811.
PMID: 33417382 - 14
Woodhouse-Sakati Syndrome Presenting With Psychotic Features After Starting Trihexyphenidyl: A Case Report.
Aljaffer MA, Almadani AH, AlMutlaq M, et al.
Cureus 2022; (14(8)):e27576 doi:10.7759/cureus.27576.
PMID: 36059322 - 15
Woodhouse-Sakati syndrome in an Indian patient with a novel pathogenic variant.
Amalnath SD, Jothivanan , Oshima J, et al.
American journal of medical genetics. Part A 2024; (194(1)):100-102 doi:10.1002/ajmg.a.63405.
PMID: 37706616 - 16
Consensus Recommendations for the Clinical Management of Wolfram syndrome Using a Delphi Method.
Elliott J, Ahmadi S, Yu-Wai-Man P, et al.
medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.07.02.26357130.
PMID: 42428113
This information about lifelong monitoring for Woodhouse-Sakati syndrome is for educational purposes only and does not constitute medical advice. Your or your child's specialists should tailor tests and timing to symptoms, age, and treatment.